Several approaches for generating improved multiperiod azeotropic design solutions are developed and are used simultaneously in a large-scale demonstration.
This review focuses on protein engineering of non-heme monooxygenases and dioxygenases for generating improved or novel functionalities.
Our research has established that the molecular marker-assisted cross-breeding technique represents a practical and highly efficient system for generating improved V. volvacea cultivars.
FLIPmal-225 μ, carrying the mutation W62A, was used as a base for generating improved FLIPmal sensors [ 9].
Together these agents hold great promise for generating improved health outcomes for type 2 diabetic patients, and with them more patients are achieving metabolic targets.
The intent here is to demonstrate both examples and possibilities for generating improved biologics, or "biobetters", from proteins or peptides that have desired pharmacological properties but less than optimal pharmacokinetic properties.
